Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Financiel contribution for travel to French-Swedish Life science day 2017, Paris, France

Reference number
Funding from Vinnova SEK 3 806
Project duration December 2017 - May 2018
Status Completed
Venture Travel grant
Call Travel grant for building international consortia

Important results from the project

The project aimed at participation in a conference arranged at the Swedish embassy in Paris, French-Swedish Life Science Day 2017, in order to present Glucox Biotech AB, to French investors and to establish business contacts among the participants.

Expected long term effects

Glucox` R&D activities and business strategy were pressed and discussed with the intention to find further financing for the continued development of the Company. Accordingly, one-to-one meetings were held with Claire Poulard, analyst at Omnes Capital, Paris, Amelia Graciet, dealflow manager at Angels Satte, Paris samt Arnaud Autet, associate at Seventure Partners, Paris. The follow-up of the meetings is now part of the Companies ordinary business development work.

Approach and implementation

The structure of the conference was divided between presentations and one-to-one meetings in a very pleasant environment in the Swedish Embassy in Paris. The meetings were booked electronically well in advance of the conference. Everything worked very well and the time schedule was adhered to perfectly.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2017-05603

Page statistics